Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.

@article{KliegerGrossmann2012PregnancyOF,
  title={Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.},
  author={Chagit Klieger-Grossmann and Brenda Weitzner and Alice Panchaud and Alessandra Pistelli and Thomas R Einarson and Gideon Koren and Adrienne RN Einarson},
  journal={Journal of clinical pharmacology},
  year={2012},
  volume={52 5},
  pages={766-70}
}
Escitalopram is a serotonin reuptake inhibitor prescribed for depression and anxiety. There is a paucity of information regarding safety in pregnancy. The objective of this study was to determine whether escitalopram is associated with an increased risk for major malformations or other adverse outcomes following use in pregnancy. The authors analyzed pregnancy outcomes in women exposed to escitalopram (n = 212) versus other antidepressants (n = 212) versus nonteratogenic exposures (n = 212) and… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Similar Papers

Loading similar papers…